酒精性肝病诊疗指南

20062Guidelinesfordiagnosisandtreatmentofalcoholicliverdis2easesFattyLiverandAlcoholicLiverDiseaseStudyGroupoftheChineseLiverDiseaseAssociation.KeywordsAlcoholicliverdiseaseDiagnosisTherapy,;;,,,,,35[1],1,1123,,,;,,,,,,[2]1.,5,40g/d,20g/d,2,80g/d,:g=(m1)(%)0182.,,;,3.(AST)(ALT)2(GGT),(TBIL),(PT)(MCV),,4,AST/ALT2,4.BCT5.12351245;125,1.:,2.:,ALTAST3.:ALTASTGGT,TBIL,,4.:,()GGTAST/ALT2AlTBIL2,,5.:[226],,,,33%()B1.(),2.3.,4.,5.124;124;1245()CT,CT420072101JClinHepatol,February2007.Vol.10,No.11,/CT1.00.7;/CT0.70.5;/CT0.5[2],;(),4(F04):F05%;F15%30%;F231%50%,F351%75%;F475%(),4(F04),4(G04):G0;G13,;G23,,Mallory,;G33,,Mallory,();G4(),4(S04):S0;S13/;S2,,;S3,;S4:2F(04)G(04)S(04)F::G::S:(),,,[7215](),:Child2Pugh2(Maddrey)(MELD),Maddrey,:4.6PT(s)+TBIL(mg/d1)():,;1.:[7]()(,,,,)()2.:,,,BC,K[8](22)3.(1)[9,10]()(2),[11]()(3)[12,13](),[12,14](22,23),()(4),(),,(GCP),,(5)()[7]()(6),36[15](22)[1]LOKAS,MCMAHONBJ.PracticeGuidelinesCommit2tee,AmericanAssociationfortheStudyofLiverDiseases(AASLD).ChronichepatitisB:updateofrecommenda2tions[J].Hepatology,2004,39:8572861.[2].[J].,2003,11,72.[3]SANYALAJ.AmericanGastroenterologicalAssociationtech2nicalreviewonnonalcoholicfattyliverdisease[J].Gastroen2terology,2002,123:170521725.[4]GRAILFM,YANUKAM,BARAZM,etal.Quantitativeestimationofattenuationinultrasoundvideoimages:cor2relationwithhistologyindiffuseliverdisease[J].InvestRadiol,2000,35:3192324.[5]ATASEVENH,YILDRIMMH,YALNIZM,etal.Cor2relationbetweencomputerizedtomographicfindingsandhistopathologicgrade/stageinnon2alcoholicsteatohepati2tis[J].JHepatol,2003,38(Suppl2):A4177.[6]FARRELLGC,GEORGEJ,PAULINEMH,etal,eds.Fattyliverdiseas:NASHandrelateddisorders[M].Ox2ford:BlackwellPublishing,2005,1592207.[7]MCCULLOUGHAJ,OCONNORJF.Alcoholicliverdisease:proposedrecommendationsfor(3)520072101JClinHepatol,February2007.Vol.10,No.1ford:BlackwellPublishing,2005.1222,1592207.[3]AmericanGastroenterologicalAssociation.AmericanGas2troenterologicalAssociationMedicalPositionstatement:nonalcoholiicfattyliverdisease[J].Gastroenterology,2002,123:170221704[4].[J].,2003,11:71.[5]SANYALAJ.AGAtechnicaireviewonnonalcoholicfattyliverdisease[J].Gastroenterology,2002,123:170521725.[6]RAMESHS,SANYALAJ.Evaluationandmanagementofnonalcoholicsteatohepatitis[J].JHepatol,2005,42:S22S12.[7]ECKELRH,GRUNDYSM,ZIMMETPZ.Themetabol2icsyndrome[J].Lancet,2005,365:141521428.[8]GRAIFM,YANUKAM,BARAZM,etal.Quantitativeestimationofattenuationinultrasoundvideoimages:cor2relationwithhistologyindiffuseliverdisease[J].InvestRadiol,2000,35:3192324.[9]ATTASEVENH,YILDRIMMH,YALNIZM,etal,Correlationbetweencomputerizedtomographicfindingsandhistopathologicgrade/stageinnon2alcoholicsteato2hepatitis[J].JHepatol,2003,38(Suppl2):A4177.[10]SCHWIMMERJB,BEHLINGC,NEWBURYR,etal,Histopathologyofpediatricnonalcoholicfattyliverdis2ease[J].Hepatology,2005,42:6412649.[11]NEUSCHWANDERT,CALDWELLSH.Nonalcohlicsteatohepatitis;summaryofanAASLDSingleTopicConference[J].Hepatology,2003,37:120221219.[12]ANGULOP.Nonalcohlicfattyliverdisease[J].NEnglJMed,2002,346:122121231.[13]GHALIP,LINDORKD.Hepatotoxicityofdrugsusedfortreatmentofobesityanditscomorbidities[J].SeminLiverDis,2004,24:3892397.[14]HARRISONSA,TORGERSONS,HAYASHIP,etal.VitaminEandvitaminCtreatmentimprovesfibrosisinpatientswithnonalcoholicsteatohepatitis[J].AmJGastroenterol,2003,98:248522490.[15]ANGULOP.Useofursodeoxycholicacidinpatientswithliverdisease[J].CurrGastroenterolRep,2002,4:37244.[16],,.()[J].,2005,10:527.[17]AGAWALS.BONKOVSKYHL.Mangementofnon2alcoholicsteatohepatitis:ananalyticreview[J].JClinGatroenterol,2002,35:2532261.[18]COMARKM,SterlingRK.Drugtherapyfornon2alco2holicfattyliverdisease[J].AlimentPharmacalTher,2006.23:2072215.(:2006202220)(:)(5)theAmericanCollegeofGastroenterology[J].AmJGas2troenterol,1998,93:202222036.[8]STICKELF,HOEHNB,SCHUPPAND,etal.Reviewarticle:Nutritionaltherapyinalcoholicliverdisease[J].AlimentPharmacolTher,2003,18:3572373.[9]MATHURINP,MENDENHALLCL,CARITHERSRL,etal.Corticosteroidsimproveshort2termsurvivalinpatientswithseverealcoholichepatitis(AH):individualdataanalysisofthelastthreerandomizedplacebocon2trolleddoubleblindtrialsofcorticosteroidsinsevereAH[J].JHepatol,2002,36:4802487.[10]IMPERIALETF,OCONNORJB,MCCULOUGHAJ.Corticosteroidsareeffectiveinpatientswithseverealco2holichepatitis.AmJGastroenterol,1999,94:306623068.[11]SHPILENYALS,MUZYCHENKOAP,GASBARRINIG,etal.Metadoxineinacutealcoholintoxication:adouble2blind,randomized,placebo2controlledstudy[J].AlcoholClinExpRes,2002,26:3402346.[12]MEDINAJ,MORENO2OTEROR.Pathophysiologicalbasisforantioxidanttherapyinchronicliverdisease[J].Drugs,2005,65:244522461.[13],,.()[J].,2005,10:527.[14]LIEBERCS,LEOMA,CAOQ,etal.Silymarinretardstheprogressionofalcohol2inducedhepaticfibrosisinba2boons[J].JClinGastroenterol,2003,37:3362339.[15]MURRAYKF,CARITHERSRL.AASLDpracticeguidelines:Evaluationofthepatientforlivertransplan2tation[J].Hepatology,2005,41:140721432.(:2006202220)(:)320072101JClinHepatol,February2007.Vol.10,No.1